FindTrial
Sign In

Two different therapies for treating nerve damage from chemotherapy

Effect of Whole Body Vibration versus Proprioceptive Neuromuscular Facilitation on Chemotherapy- Induced Peripheral Neuropathy: A Randomized Clinical Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071675
Enrollment
38
Registered
2024-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Whole Body Vibration and regular physiotherapy treatment: Each training session consisted of four progressing sets of 30-s to 1-min vibration, with a frequency from 18 to 35 Hz and ampl

Sponsors

Srushti Jegarkal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Willing to participate. Age 18-70 years all genders. Diagnosed case of CIPN. Minimum 3 doses of chemotherapy or have completed chemotherapy treatment.

Exclusion criteria

Exclusion criteria: Severe neuropathic symptoms requiring immediate medical care. Pre-existing peripheral neuropathy not related to chemotherapy treatment. Individuals with a history of severe cardiovascular disease or orthopedic conditions. Cognitive impairment or psychiatric disorders. Unstable medical conditions.

Design outcomes

Primary

MeasureTime frame
Self-report Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) Semmes Weinstein Monofilament MiniBESTest Functional Assessment of Cancer Therapy/ Gynecologic Oncology Group Neurotoxicity (FACT-GOG Ntx)(v4) Timepoint: Baseline and after 3 weeks—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactSrushti Jegarkal

KAHER Institute of Physiotherapy

sanjiv3303@rediffmail.com9448745648

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026